Silencing of SiX-4 enhances the chemosensitivity of melanoma cells to Cisplatin-Reference-Cited by-同舟云学术

Silencing of SiX-4 enhances the chemosensitivity of melanoma cells to Cisplatin

Published:2022-12 Issue: Volume:240 Page:154194
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

vazirabad Aysan Fallah,Noorolyai Saeed,Baghbani Elham,Mahboob Soltanali,Zargari Felor,rahmani Shima,Sorkhabi Amin,montazami Nooshin,Sameti Pouriya,Baradaran Behzad

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference31 articles.

1. Recent trends in cutaneous melanoma incidence among whites in the United States;Jemal;J. Natl. Cancer Inst.,2001

2. Immunotherapy for melanoma;Kim;Cancer Control,2002

3. Metastatic melanoma: chemotherapy to biochemotherapy;O'day;Cancer Control,2002

4. Nucleolin-targeting liposomes guided by aptamer AS1411 for the delivery of siRNA for the treatment of malignant melanomas;Li;Biomaterials,2014

5. Apoptosis and melanoma: how new insights are effecting the development of new therapies for melanoma;Hersey;Curr. Opin. Oncol.,2006

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resveratrol suppresses NSCLC cell growth, invasion and migration by mediating Wnt/β-catenin pathway via downregulating SIX4 and SPHK2;Journal of Chemotherapy;2023-11-15

2. Plasma Methylated DNA Markers for Melanoma Surveillance;JCO Precision Oncology;2023-09

3. Current status of skin cancers with a focus on immunology and immunotherapy;Cancer Cell International;2023-08-21

4. The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies;Frontiers in Immunology;2023-03-20

5. CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment;Journal of Cancer Research and Clinical Oncology;2023-03-11